These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28527345)

  • 21. A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data.
    Partridge E; Trobbiani S; Stockham P; Charlwood C; Kostakis C
    J Anal Toxicol; 2018 Nov; 42(9):655-660. PubMed ID: 29945197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.
    Tyrkkö E; Andersson M; Kronstrand R
    Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recreational use, analysis and toxicity of tryptamines.
    Tittarelli R; Mannocchi G; Pantano F; Romolo FS
    Curr Neuropharmacol; 2015 Jan; 13(1):26-46. PubMed ID: 26074742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
    Hondebrink L; Zwartsen A; Westerink RHS
    Pharmacol Ther; 2018 Feb; 182():193-224. PubMed ID: 29097307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands.
    de Jong LAA; Olyslager EJH; Duijst WLJM
    J Forensic Leg Med; 2019 Jul; 65():101-104. PubMed ID: 31129558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput screening for new psychoactive substances (NPS) in whole blood by DLLME extraction and UHPLC-MS/MS analysis.
    Odoardi S; Fisichella M; Romolo FS; Strano-Rossi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():57-68. PubMed ID: 26209771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of new psychoactive substances: A retrospective study in hair.
    Rust KY; Baumgartner MR; Dally AM; Kraemer T
    Drug Test Anal; 2012 Jun; 4(6):402-8. PubMed ID: 22522922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmortem distribution and redistribution of MDAI and 2-MAPB in blood and alternative matrices.
    Staeheli SN; Boxler MI; Oestreich A; Marti M; Gascho D; Bolliger SA; Kraemer T; Steuer AE
    Forensic Sci Int; 2017 Oct; 279():83-87. PubMed ID: 28850871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. n-Ethyl Pentylone-Related Deaths in Alabama.
    Atherton D; Dye D; Robinson CA; Beck R
    J Forensic Sci; 2019 Jan; 64(1):304-308. PubMed ID: 29768653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples.
    Salomone A; Gazzilli G; Di Corcia D; Gerace E; Vincenti M
    Anal Bioanal Chem; 2016 Mar; 408(8):2035-42. PubMed ID: 26680593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.
    Pasin D; Bidny S; Fu S
    J Anal Toxicol; 2015 Apr; 39(3):163-71. PubMed ID: 25552261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review.
    Pasin D; Cawley A; Bidny S; Fu S
    Anal Bioanal Chem; 2017 Oct; 409(25):5821-5836. PubMed ID: 28634759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
    Wood DM; Sedefov R; Cunningham A; Dargan PI
    Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentrations of alprazolam in blood from impaired drivers and forensic autopsies were not much different but showed a high prevalence of co-ingested illicit drugs.
    Jones AW; Holmgren A
    J Psychopharmacol; 2013 Mar; 27(3):276-81. PubMed ID: 23257168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical toxicology of emerging drugs of abuse.
    Peters FT; Martinez-Ramirez JA
    Ther Drug Monit; 2010 Oct; 32(5):532-9. PubMed ID: 20814349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of "new psychoactive substances" in postmortem matrices using microwave derivatization and gas chromatography-mass spectrometry.
    Margalho C; Castanheira A; Real FC; Gallardo E; López-Rivadulla M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():14-23. PubMed ID: 26994330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatalities related to new psychoactive substances in Singapore-A case series.
    Chan S; Wu J; Lee B
    Forensic Sci Int; 2019 Nov; 304():109892. PubMed ID: 31395407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB).
    Adamowicz P; Zuba D; Byrska B
    Forensic Sci Int; 2014 Dec; 245():126-32. PubMed ID: 25447185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Presence of New Psychoactive Substances in a Tor Network Marketplace Environment.
    Dolliver DS; Kuhns JB
    J Psychoactive Drugs; 2016; 48(5):321-329. PubMed ID: 27660913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioanalytical Methods for New Psychoactive Substances.
    Wagmann L; Maurer HH
    Handb Exp Pharmacol; 2018; 252():413-439. PubMed ID: 29374833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.